Solid Phase Oligonucleotide Synthesis Is Not Obsolete - It Is Ascending
Solid-phase oligonucleotide synthesis remains the backbone of therapeutics, with flow-enabled SPOS delivering unmatched control, scalability, and regulatory reliability.
Resources
Scientific explanations, concepts and technical analysis.
9 of 30 resources
Solid-phase oligonucleotide synthesis remains the backbone of therapeutics, with flow-enabled SPOS delivering unmatched control, scalability, and regulatory reliability.
Discover kbDNA’s rapid workflow for repurifying rituximab biosimilars to high-purity standards—featuring SEC overlays, gel schematics, and SOPs.
This article explores the complexities of biosimilars, including their development process, regulatory challenges, economic impact, and future prospects. It highlights the potential of biosimilars to reduce healthcare costs and increase patient access to biologic therapies, providing valuable insights for biopharmaceutical and academic researchers.
The FLAG tag (DYKDDDDK) is an epitope tag widely utilized in biopharmaceutical research for protein purification, detection, and functional analysis. This article provides an in-depth examination of FLAG tag technology, its advantages, limitations, and diverse applications. Additionally, it explores current research trends and future directions in FLAG tag technology, making it a pivotal tool in advancing drug discovery and development.
Discover the latest advancements in peptide synthesis at kbDNA. Learn about innovative techniques, optimized reagents, and cutting-edge technologies that enhance research efficiency and outcomes.
What are Polyclonal Antibodies? pAbs are diverse antibodies from various B-cell clones, binding multiple epitopes & enabling vast interaction with targets.
Discover the transformative impact of CRISPR-Cas9 in biomedical research and genetic engineering, covering its mechanism, applications, challenges, and ethical considerations. The article also highlights alternative CRISPR systems like Cas12 and Cas13.
"Explore the critical role of membrane proteins in medicine. Learn how understanding their structure informs drug development, shaping the future of healthcare."
Unlock the complexities of protein characterization in bio-pharmaceutical research. Explore methods, applications, and emerging trends.
Discover protein linkers' diverse roles: from structural stability to cell signaling in molecular engineering.
Discover how Fusion Proteins revolutionize gene editing, nanotechnology, and synthetic biology, driving breakthroughs in science and medicine.
Learn about monoclonal antibodies: their history, production, types, and applications in medicine. Dive into challenges, future prospects & more.
Explore the advantages of recombinant antibodies. Discover their applications in research, diagnostics & therapeutics. Transform your R&D with precision.
An October 2023 overview of research-grade reagents and factors that affect their suitability for discovery-stage research.
Examples of bioconjugation based hybrid molecules include protein structure elucidation using tags, enzyme immobilization, antibodies binding to fluorophores, cellular imaging, microarrays, etc.
In order to utilize protein reagents for desired applications, there is urgent requirement of improved quality control (QC) in terms of purity, production and reproducibility. Quality control of protein reagents deemed essential for precise measurement system and ensures reproducibility over time under different operating conditions. Our latest article outlines key aspects of minimal criteria and makes a case for optimizing standard RUO testing.
Bioseparation studies helped lay the groundwork for innovations in purification techniques. Particularly with the various chromatography methods, its a challenge to analyze principles with parameters to match your experiment criteria. In our new article, we investigate this by focusing on the distinct chemistry of each method; size-exclusion, ion-exchange and affinity chromatography.
Characterization plays a comprehensive role throughout discovery. For structural biologists, this entails gaining a better understanding of biophysical and dynamic properties relative to their research molecules. While various disciplines continue to help innovate methods used for structural studies-the recent introduction of cryo-electron microscopy (cryo-EM) has been a significant addition to the experimental workflow. In this note, we review and compare primary methods for structural characterization, while exploring the true application potential for Cryo-EM.
Post Translational Modifications (PTMs) are a growing focus in protein and bioreagent production. We review the top key understandings and mechanics of PTMs with up-to-date biochemistry.
Reviewing the conventional aptamer : antibody side by side comparison. By utilizing our professional experiences with both reagents to highlight some essential oversights between the two, we make a case for implementing both reagents in your experimental workflow to reinforce your discovery platform. Read more about it in this op-ed article!
Oligonucleotide aptamer assays have been proven tactical in accelerating drug discovery platforms. Single-site or dual-site binding, the utility of aptamer science offers significant advantages in detecting your target molecules. Learn about oligo-aptamer assays & consider their application in your experiment workflow.
The upsurge in infectious disease research prompts immense RNA isolation techniques for sample preparation. High purity extraction of the viral RNA is critical for characterization analysis and drug discovery. Learn how spin-column and magnetic bead-based method compare when it comes to your viral RNA extraction.
In our publication, we provide the current knowledge of linker properties, design and functionality in recombinant fusion protein technology
Explore the topic of drug targeting selectivity in coronaviruses. Analysis of key genomic & structural elements of the virus provides an understanding of the research challenges while making a case for siRNA synthetic reagents for antisense target optimization.
Recent success in targeting covalent inhibitors has increased consideration of covalent molecules in target discovery. Gain insight on the current nucleophile modalities, electrophile warheads & innovative methods helping drug hunters advance small-molecule research.
Relative to the central dogma of molecular biology, our synthetic dogma explains the profiles of DNA, RNA & Protein as analyte-specific research reagents and their applications throughout the workflow of experiments for drug discovery; ssDNA, dsRNA, recombinants
CRISPR/CAS9 is innovating drug discovery & laboratory research methods, but off-targeting remains an issue. Modifying the single guide RNA emerges as an effective solution. Rational design & engineering secondary structure offer capabilities to apply diverse gRNA types as hairpins to optimize specificity.
A 2019 perspective on the challenges of sourcing difficult-to-express recombinant proteins, including kbDNA’s protein work at the time.
Finding the right modifications to build a DNA or RNA sequence can be overwhelming, a problem that has resulted in a growing trend of laboratories dedicating valuable time and money to unnecessary and expensive modifications, sequence designs that overlook biochemistry fundamentals, and widespread misinformation. With a growing need for biochemists in nucleotide synthesis labs, there is an equal need to re-establish an understanding of the different types of modifications and the roles they play in synthesis.
Review of the technical components that drive attachment chemistry in nucleotide synthesis. Building blocks; amidites/phospho-amidites, supports including a wide range of modifications in oligonucleotides for DNA or RNA drug discovery experiments